Anhui Huaren Health Pharmaceutical's (SZSE:301408) Weak Earnings May Only Reveal A Part Of The Whole Picture
May 07
Chinese (SSE) Drug Retail Industry Analysis
UpdatedMay 19, 2024
DataAggregated Company Financials
Companies9
- 7D-0.1%
- 3Mn/a
- 1Y-4.0%
- YTDn/a
Over the last 7 days, the Drug Retail industry has dropped 1.6%, driven by Yifeng Pharmacy Chain declining 2.8%. As for the longer term, the industry's performance has been flat for the past year. As for the next few years, earnings are expected to grow by 20% per annum.
Industry Valuation and Performance
Has the Chinese Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 19 May 2024 | CN¥126.9b | CN¥118.3b | CN¥4.8b | 26.4x | 26.6x | 1.1x |
| Tue, 16 Apr 2024 | CN¥119.7b | CN¥114.8b | CN¥5.2b | 22.5x | 23x | 1x |
| Thu, 14 Mar 2024 | CN¥118.1b | CN¥115.9b | CN¥5.8b | 20x | 20.3x | 1x |
| Sat, 10 Feb 2024 | CN¥122.1b | CN¥116.0b | CN¥5.7b | 20.5x | 21.3x | 1.1x |
| Mon, 08 Jan 2024 | CN¥130.9b | CN¥116.0b | CN¥5.7b | 22.7x | 22.8x | 1.1x |
| Wed, 06 Dec 2023 | CN¥128.2b | CN¥116.0b | CN¥5.7b | 22.7x | 22.4x | 1.1x |
| Fri, 03 Nov 2023 | CN¥118.5b | CN¥115.8b | CN¥5.7b | 21.6x | 20.7x | 1x |
| Sun, 01 Oct 2023 | CN¥120.4b | CN¥113.6b | CN¥5.7b | 23.1x | 21.2x | 1.1x |
| Tue, 29 Aug 2023 | CN¥122.5b | CN¥111.0b | CN¥5.5b | 25.7x | 22.2x | 1.1x |
| Thu, 27 Jul 2023 | CN¥129.9b | CN¥109.7b | CN¥5.4b | 27.4x | 23.9x | 1.2x |
| Sat, 24 Jun 2023 | CN¥132.1b | CN¥109.7b | CN¥5.4b | 27.8x | 24.3x | 1.2x |
| Mon, 22 May 2023 | CN¥132.1b | CN¥109.7b | CN¥5.4b | 27.3x | 24.3x | 1.2x |
| Wed, 19 Apr 2023 | CN¥141.3b | CN¥95.3b | CN¥4.4b | 37.4x | 32x | 1.5x |
| Fri, 17 Mar 2023 | CN¥142.9b | CN¥90.3b | CN¥4.0b | 35x | 35.5x | 1.6x |
| Sun, 12 Feb 2023 | CN¥138.0b | CN¥90.3b | CN¥4.0b | 34.1x | 34.3x | 1.5x |
| Tue, 10 Jan 2023 | CN¥151.8b | CN¥90.3b | CN¥4.0b | 39x | 37.7x | 1.7x |
| Thu, 08 Dec 2022 | CN¥156.4b | CN¥90.3b | CN¥4.0b | 39.9x | 38.8x | 1.7x |
| Sat, 05 Nov 2022 | CN¥141.8b | CN¥90.3b | CN¥4.0b | 42x | 35.5x | 1.6x |
| Mon, 03 Oct 2022 | CN¥113.2b | CN¥85.6b | CN¥3.8b | 35.1x | 29.6x | 1.3x |
| Wed, 31 Aug 2022 | CN¥120.8b | CN¥81.5b | CN¥3.7b | 39.3x | 32.5x | 1.5x |
| Fri, 29 Jul 2022 | CN¥119.4b | CN¥80.8b | CN¥3.7b | 38.5x | 32x | 1.5x |
| Sun, 26 Jun 2022 | CN¥118.2b | CN¥80.8b | CN¥3.7b | 38.3x | 31.7x | 1.5x |
| Tue, 24 May 2022 | CN¥99.6b | CN¥80.8b | CN¥3.7b | 30.6x | 26.7x | 1.2x |
| Thu, 21 Apr 2022 | CN¥92.7b | CN¥75.6b | CN¥4.0b | 25.7x | 23x | 1.2x |
| Sat, 19 Mar 2022 | CN¥105.2b | CN¥75.3b | CN¥4.1b | 29.3x | 26x | 1.4x |
| Mon, 14 Feb 2022 | CN¥121.4b | CN¥74.7b | CN¥4.1b | 33.9x | 29.8x | 1.6x |
| Wed, 12 Jan 2022 | CN¥137.7b | CN¥74.7b | CN¥4.1b | 38.3x | 33.8x | 1.8x |
| Fri, 10 Dec 2021 | CN¥132.3b | CN¥74.7b | CN¥4.1b | 35.5x | 32.4x | 1.8x |
| Sun, 07 Nov 2021 | CN¥130.1b | CN¥74.7b | CN¥4.1b | 34.4x | 31.9x | 1.7x |
| Tue, 05 Oct 2021 | CN¥126.5b | CN¥72.0b | CN¥4.2b | 30.5x | 30.3x | 1.8x |
| Thu, 02 Sep 2021 | CN¥133.5b | CN¥72.0b | CN¥4.2b | 31.3x | 32x | 1.9x |
| Sat, 31 Jul 2021 | CN¥123.4b | CN¥72.0b | CN¥4.2b | 30.4x | 29.6x | 1.7x |
Price to Earnings Ratio
41.6x
Current Industry PE
- Investors are relatively neutral on the Chinese Drug Retail industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 28.7x.
- The 3-year average PS ratio of 1.4x is higher than the industry's current PS ratio of 1.1x.
Past Earnings Growth
- The earnings for companies in the Drug Retail industry have grown 8.0% per year over the last three years.
- Revenues for these companies have grown 22% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does Chinese Drug Retail compare with similar industries?
| CN Market | 0.029% | |
| Consumer Staples | -0.38% | |
| Food and Staples Retail | -0.017% | |
| Drug Retail | -0.13% | |
| Big Box Super Stores | 4.00% | |
| Food Retail | -0.81% | |
| Food Distributors | -2.11% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 603233 DaShenLin Pharmaceutical Group | CN¥22.94 | 3.7% +CN¥933.9m | -16.6% | PE24.5x | |
| 2727 Yixintang Pharmaceutical Group | CN¥22.65 | 3.5% +CN¥453.0m | -16.3% | PE24.5x | |
| 605266 Jianzhijia Pharmaceutical Chain Group | CN¥51.50 | 1.7% +CN¥112.1m | -11.3% | PE17x | |
| 301408 Anhui Huaren Health Pharmaceutical | CN¥12.78 | 0.9% +CN¥48.0m | -28.3% | PE38.4x |
